Pfizer Q3 income skyrockets 5.5 times thanks to vaccine
Excluding items, adjusted income for the quarter was $1.34 per share, compared to $0.59 per share in the year ago quarter.
Total revenues for the quarter soared 134 percent to $24.09 billion from $10.28 billion in the same quarter last year.
Excluding Comirnaty, revenues grew only 7 percent. ■